SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (651)12/1/1998 1:28:00 PM
From: Dan Spillane  Read Replies (2) | Respond to of 2539
 
But that is an incorrect rationale as well...if Cox-2s don't work as some suddenly believe, Merck is in big trouble. Not a matter of when at all...more like NEVER for everyone involved, including Merck.

You said:
MRK's up - the rationale is that Vioxx would be approved first, would then be the first Cox-2 inhibitor out.